[ad_1] SILVER SPRING, Maryland – The United States Food and Drug Administration alerts health care professionals and patients to the voluntary recall of several drugs containing valsartan, an active ingredient used to …
Read More »[ad_1] OTTAWA July 9, 2018 / CNW / – Version: Several manufacturers of the valsartan ingredient are recalled by their manufacturers. An impurity, N-nitrosodimethylamine (NDMA), has been found in valsartan used in …
Read More »
[ad_1] The decision was made after the manufacturer of the active pharmaceutical ingredient (API) Zhejiang Hauhai notified the European Medicines Agency (EMA) that she had detected an impurity in her production of …
Read More »